医薬品調査レビュー　2023年

Report Highlights

• The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.
• The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
• The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

Research Review Scope

The pharmaceutical market is one of the biggest industries in the world, and it is continuously growing. Continuous and ongoing research and development are happening in the pharmaceutical market, with the entry of new drugs and the performance of the current drugs. However, a drug’s entry into the market takes around 12-13 years, but the market for existing drugs keeps soaring, which is why the pharmaceutical market keeps growing.

医薬品市場は世界最大の産業の 1 つであり、成長を続けています。医薬品市場では継続的かつ進行中の研究開発が行われており、新薬の参入と現行薬の性能が向上しています。ただし、医薬品が市場に投入されるまでには約 12 ～ 13 年かかりますが、既存の医薬品市場は高騰を続けており、それが医薬品市場が成長し続けている理由です。

Research and development play a vital role in the growth of the pharmaceutical market, driven by technological and scientific advancements, especially in cell and gene therapies. The market is affected by stringent regulatory and reimbursement policies and escalating research and development costs. Artificial intelligence can be considered crucial with its usage in multiple fields of pharmaceuticals, such as drug discovery, clinical trials, drug screening, personalized medicine, supply chain management, regulatory compliance, pharmacovigilance, and marketing insights. Generative AI tools help accelerate drug discovery by automating tedious and time-consuming tasks.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2023 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2023:

-PHM281A Anti Obesity Drugs Market

– PHM013J Drugs of Abuse Testing: Technologies and Global Markets

– BIO009H Global Markets for Bioengineered Protein Drugs

– HLC026G The Global Market for Pain Management Drugs and Devices

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

Research Review Scope

Chapter 2 Global Market for Anti-obesity Drugs (PHM281A)

Anti-obesity Drugs

Study Goals and Objectives

Reasons for Doing this Study

Scope of Report

Market Outlook

Market Summary

Market Overview of Anti-obesity Drugs

Definitions of Adult Obesity and Overweight

Rising Prevalence of Obesity

Impact of Obesity on Global Economy

Increasing Awareness Regarding Obesity

Global Market for Anti-obesity Drugs, by Type

Prescription Drugs

Over-the-Counter Anti-obesity Drugs

Global Market for Anti-obesity Drugs, by Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Market for Anti-obesity Drugs, by Region

North America

Europe

Asia-Pacific

Rest of the World

ESG Developments of Anti-obesity Drugs

Importance of ESG in Anti-obesity Drugs Industry

ESG Pillars in the Anti-obesity Drug Industry

ESG Ratings and Metrics: Understanding the Data

ESG Practices in the Anti-obesity Drug Industry

Concluding Remarks from BCC

Chapter 3 Drugs of Abuse Testing: Technologies and Global Markets (PHM013J)

Drugs of Abuse Testing

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Summary and Highlights

Market and Technology Background of Drugs of Abuse Testing

Overview

Testing Technologies

Single Tests vs. Multiparameter Tests

DOA Screening

Porter’s Five Forces Analysis of Drugs of Abuse Testing

Market Dynamics of Drugs of Abuse Testing

Market Drivers

Market Restraints

Market Opportunities

Regulatory Scenario of Drugs of Abuse Testing

North America

South America

Central America and the Caribbean

Europe

Asia-Pacific

Global Drugs of Abuse Testing Market, by Drug Type

Alcohol

Amphetamine and Methamphetamine

Cannabis/Marijuana

Cocaine

Opioids

Others

Global Drugs of Abuse Testing Market, by End User

Drug Testing Laboratories

Hospitals

Workplaces

Others

Market Breakdown of Drugs of Abuse Testing, by Region

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 4 Global Markets for Bioengineered Protein Drugs (BIO009H)

Bioengineered Protein Drugs

Study Goals and Objectives

Scope of This Report

Market Summary

Market and Technology Background of Bioengineered Protein Drugs

Protein Drugs Overview

Bioengineered Protein Drugs

Manufacturing Technologies of Bioengineered Protein Drugs

Fractionation/Extraction from Natural Sources (Human/Animal)

Microbial Fermentation and Bioreactors

Transgenics

Mammalian Cell Culture

Market Dynamics of Bioengineered Protein Drugs

Market Driver

Market Challenges

Market Breakdown of Bioengineered Protein Drugs by Drug Type

Overview

Monoclonal Antibodies (mAbs)

Peptide Hormones

Vaccines

Fusion Proteins

Blood Factors

Peptide Antibiotics

Cytokines

Therapeutic Enzymes

Market Breakdown of Bioengineered Protein Drugs, by Disease

Overview

Market Breakdown of Bioengineered Protein Drugs, by Region

North America Market Revenue, by Drug Type

Europe Market Revenue, by Drug Type

Emerging Markets Revenue, by Drug Type

Regulatory Aspects and New Approvals of Bioengineered Protein Drugs Market

New Approvals

Emerging Trends/Upcoming Technologies in the Market

Bi- and Multi-Specific Antibodies

Key Trends in Biopharmaceutical Industry

Chapter 5 Global Market for Pain Management Drugs and Devices (HLC026G)

Pain Management Drugs and Device

Study Goals and Objectives

Reasons for Doing this Study

Scope of Report

Market Outlook

Market Summary

Highlights of the Market for Pain Management Drugs and Devices

Market Overview of Pain Management Drugs and Device

History of Pain and Pain Treatment

The Perception of Pain

Types of Pain

Assessment of Pain

How Pain is Diagnosed

How Pain is Treated

Market Dynamics of Pain Management Drugs and Device

Market Drivers

Market Restraints

Market Challenges

Market Breakdown of Pain Management Drugs and Device, by Product

Pharmaceuticals

Pain Management Devices

Market Breakdown of Pain Management Drugs and Device, by Application

Musculoskeletal Pain

Post-operative Pain

Neuropathic Pain

Cancer Pain

Migraine/Headache

Other Applications

Market Breakdown of Pain Management Drugs and Device, by Region

North America

Europe

Asia-Pacific

Rest of the World

ESG Development of Pain Management Drugs and Device

Introduction to ESG

Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective

Case Study

Concluding Remarks from BCC

Emerging Technologies of Pain Management Drugs and Device

Overview

Technology Advancements in Opioid Drugs

Technology Advancements in Non-narcotic Drugs

Technology Advancements in Neuromodulation Devices

Technology Advancements in Infusion Pumps

Trends in Pain Management

Chapter 6 Appendix

Methodology

Analyst’s Credentials

List of Tables

Table 1 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028

Table 2 : Definitions of Adult Obesity and Overweight

Table 3 : Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020–2035

Table 4 : Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020–2035

Table 5 : Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035

Table 6 : Global Economic Impact of High BMI (BMI ≥25kg/m²), 2020–2035

Table 7 : Global Market for Anti-obesity Drugs, by Drug Type, Through 2028

Table 8 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028

Table 9 : Global Market for Anti-obesity Drugs, by Region, Through 2028

Table 10 : ESG Ratings and Metrics of Anti-obesity Drugs

Table 11 : Environmental Performance of Anti-obesity Drugs

Table 12 : Social Performance of Anti-obesity Drugs

Table 13 : Governance Performance of Anti-obesity Drugs

Table 14 : ESG Rankings for Major Anti-obesity Drug Companies, 2023*

Table 15 : Global Market for Drugs of Abuse Testing, by Region, Through 2027

Table 16 : Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine

Table 17 : Deaths from Tobacco, Alcohol and Drugs, Across Countries, 2019

Table 18 : Commonly Abused Drugs

Table 19 : Prevalence of Drug Use in General, Population Across Region, 2020

Table 20 : Global Drug Seizure, by Drug Type, 2020

Table 21 : U.S. Drug Testing Legislation, by State, 2017

Table 22 : European Drug Testing Legislation, by Country

Table 23 : Global Market for Drugs of Abuse Testing, by Region, Through 2027

Table 24 : Global Market for Bioengineered Protein Drugs, by Drug Type, Through 2027

Table 25 : Characteristics of Large Molecule/Protein Drugs

Table 26 : Bioengineered Protein Drugs vs. Chemically Synthesized Drugs

Table 27 : Selected Protein Drugs Made, by Fractionation

Table 28 : Selected Therapeutic Drugs Produced, by Microbial Fermentation

Table 29 : Selected Protein Drugs Produced, by Transgenic Animals, Plants, and Microorganisms

Table 30 : Selected Protein Drugs Made, by Cell Culture

Table 31 : Number and Distribution of Persons Aged 60+, by Region, 2019 and 2050

Table 32 : Global Pipeline Molecules, by Type, Through 2021

Table 33 : Global Market for Bioengineered Protein Drugs, by Drug Type, Through 2027

Table 34 : Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method

Table 35 : Global Market for Bioengineered Protein Drugs, by Disease, Through 2027

Table 36 : Global Market for Bioengineered Protein Drugs, by Region, Through 2027

Table 37 : Newly Approved Monoclonal Antibodies (mAbs), January 2021–December 2022

Table 38 : Newly Approved Peptide Hormones and Drugs, January 2021-December 2022

Table 39 : Newly Approved Vaccines, January 2021–December 2022

Table 40 : Vaccine Candidates in Clinical Phase, January 2021–December 2022

Table 41 : Newly Approved Blood Factors, January 2021-December 2022

Table 42 : Newly Approved Peptide Antibiotics, January 2021-December 2022

Table 43 : Newly Approved Therapeutic Enzymes, January 2021-December 2022

Table 44 : Newly Approved Cytokines, January 2021-December 2022

Table 45 : Newly Approved Fusion Protein, January 2021-December 2022

Table 46 : Selected Bi-Specific Antibodies in Phase 3 Clinical Trials, 2023

Table 47 : Global Market for Pain Management Drugs and Devices, by Product, Through 2028

Table 48 : Global Market for Pain Management Drugs and Devices, by Region, Through 2028

Table 49 : Objective Signs of Pain

Table 50 : Prevalence of Chronic Pain in Older Adults, by Site

Table 51 : Opioid Lawsuit Settlements

Table 52 : Global Market for Pain Management Drugs and Devices, by Product, Through 2028

Table 53 : FDA Pain Management Drug Approvals, 2020-2023

Table 54 : Pain Management Major Drugs, by Company

Table 55 : Emerging Pain Therapeutics

Table 56 : Global Market for Pain Management Pharmaceuticals, by Product, Through 2028

Table 57 : Global Market for Pain Management Devices, by Type, Through 2028

Table 58 : Global Market for Pain Management Drugs and Devices, by Application, Through 2028

Table 59 : Cumulative Volumes of Hip and Knee Procedures, 2012-2021

Table 60 : Neuropathic Pain Medication

Table 61 : Cancer Pain Medication

Table 62 : Global Market for Pain Management Drugs and Devices, by Region, Through 2028

Table 63 : ESG Ranking of Major Pharma Players for Pain Therapeutics, 2022

Table 64 : ESG Rankings for Major Pain Management Drug and Device Companies, 2023*

Table 65 : ESG: Environmental Overview

Table 66 : ESG: Social Overview

Table 67 : ESG: Governance Overview

List of Figures

Figure 1 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028

Figure 2 : Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028

Figure 3 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028

Figure 4 : Global Market Shares of Anti-obesity Drugs, by Region, 2021-2028

Figure 5 : Global Market Shares of Drugs of Abuse Testing, by Region, 2021

Figure 6 : Annual Self-reported Alcohol-impaired Driving Episodes Among U.S. Adults, 2010-2020

Figure 7 : Legal Adult-Use Cannabis Sales Worldwide, 2020-2025*

Figure 8 : Global Market Shares of Drugs of Abuse Testing, by Region, 2021

Figure 9 : Global Market for Bioengineered Protein Drugs, by Drug Type, 2019-2027

Figure 10 : Global Market Shares of Bioengineered Protein Drugs, by Drug Type, 2021

Figure 11 : Global Market Shares of Bioengineered Protein Drugs, by Disease, 2021

Figure 12 : Snapshot of Global Market for Bioengineered Protein Drugs, by Region

Figure 13 : Global Market Shares of Bioengineered Protein Drugs, by Region, 2021

Figure 14 : NDAs and BLA Approvals in Market for Bioengineered Protein Drugs, by Drug Type, 2021 and 2022

Figure 15 : Share of NDAs and BLA Approvals in Market for Bioengineered Protein Drugs, by Drug Type, 2021 and 2022

Figure 16 : Global Market for Pain Management Drugs and Devices, by Product, 2020-2028

Figure 17 : Global Market for Pain Management Drugs and Devices, by Region, 2020-2028

Figure 18 : Pain Management Techniques

Figure 19 : Pain Management Drugs and Devices: Market Dynamics

Figure 20 : Common Chronic Pain: Reasons

Figure 21 : Cancer Incidence, by Region, 2020 vs. 2040

Figure 22 : Percentage of Global Population Above 65 Years, 2018-2022

Figure 23 : Global Market Shares of Pain Management Drugs and Devices , by Product, 2022

Figure 24 : Global Market Shares of Pain Management Pharmaceuticals, by Product, 2022

Figure 25 : Global Market Shares of Pain Management Devices, by Type, 2022

Figure 26 : Global Market Shares of Pain Management Drugs and Devices, by Application, 2022

Figure 27 : Classification of Neuropathic Pain

Figure 28 : Causes of Cancer Pain

Figure 29 : Burn Pain Management Approach

Figure 30 : Global Market Shares of Pain Management Drugs and Devices, by Region, 2022

Figure 31 : ESG Pillars

Figure 32 : Advantages of ESG for Companies

Figure 33 : ESG-Adoption Level across Industries

Figure 34 : Hospitals: Sustainability Priorities

Figure 35 : Novartis: ESG Rating

Figure 36 : Novartis: Major ESG Activities, 2022

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• バイオプラスチックの世界市場と技術 2025-03-07
• 半導体製造調査レビュー　2024年 2025-03-06
• 製造市場レビュー　2024年 2025-03-05
• 計測器とセンサの調査レビュー　2024年 2025-03-05
• 航空宇宙用先端材料の世界市場 2025-03-05

BCC Research  出版レポート一覧